Exam 2 lecture 4 pt 2 Flashcards

1
Q

What bacteria are aminoglycosides primarily active against

A

Primarily active against aerobic bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What organisms should we be looking at for Aminoglycosides

A

Staph Aureus
Pseudomonas aeroginosa
enterococcus
MDR gram negatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is special about aminoglycosides

A

Group antibiotics that are dosed individually for each patient and require serum concentration monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the most commonly used aminoglycosides

A

Gentamycin
Tobramycin
Amikacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Are aminoglycosides polar or non polar? How does this affect their MOA

A

Are very polar

Polycationic
Water soluble
Incapable of crosiing lipid membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What bond holds aminoglycosides together?

A

glycosidic bond (oxygen between rings)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of aminoglycosides? Bacteiostatic/cidal? why?Time/concentration?

A

Are one of the only protein synthesis inhibitors that are cidal in nature. This is bc it irreversibly bind 30S subunit.

Concentration dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of resistance of aminoglycoside

A
  1. Synthesis of aminoglycoside modifying enzyme (most common)
    - Plasmid mediated; enzyme modifies structure of aminoglycoside leading to poor uptake and ribosomal binding
  2. Alteration in ribosomal binding sites
  3. Alteration in aminoglycoside uptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cross resistance of Aminoglycoside

A

Tobramycin and gentamycin have cross resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drug do we primarily see alteration in ribosomal binding? Why?

A

Streptomycin only binds to a single site.

Genta, tobra, amika bind to multiple sites so they can still exert activity by binding other sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

spectrum of activity of aminoglycosides (what type of bacteria is it primarily active against?)

A

Primarily aerobic bacteria

For gram positives we ALWAYS use them in combinations

For gram negative we often use them in combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What dose should aminoglycosides be used in in gram positive vs gram negative agents

A

Gram positive- low dose
Gram negative- high dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What gram positive aerobes is aminoglycoside active against? What is the target organism?

A

Viridians streptococci (gent)
Enterococcus spp (gent or strepto)
most S aureus* (target organism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are gram negative aerobes aminoglycosides are used in? What is the target organism What drugs are used for gram negative aerobes

A

Gentamamycin, Tobramycin, amikacin and plazomycin

E coli, K pneumonia, proteus spp, Acinetobacter (not P), citrobacter, enterobacter spp, morganella, salmonella, providencia, serratia, shigella

Pseudomonas aeruginosa* (target organism)

PPPEEACKSSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Do we use gent for monotherapy for MSSA or MRSA

A

No, always in combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which Aminoglycosides are the most effective for gram negative aerobes/ cover more strains

A

Amikacin and plazomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Does plazomycin have activity against acinetobacter?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Do aminoglycosides act against anaerobes?

A

Inactive against anaerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is post antibiotic effect (PAE)? Do aminoglycosides have it?

A

PAE is suppression of bacterial growth after serum concentrations have fallen below MIC

20
Q

What are aminoglycosides synergistic with? What does this synergism target?

A

Observed with AGs and cell wall active agents against enterococcus spp, staphylococcus spp, ciridians strep and gram negatives

21
Q

WHat are soe cell wall active agents

A

B lactams and vancomycin

22
Q

Can aminoglycosides be used as monotherapy for tx of infections due to gram positive aerobes

A

No, they should always ben used with cell wall active antibiotics in tx of infections to gram positive aerobes

23
Q

Are aminoglycosides polar or non polar? How does this affect PK characteristics?

A

Highly polar

SO water soluble they are eliminated unchanged

24
Q

Why do we individualize dosing of aminoglycosides

A

Interpatient variability exists in Vd and clearence

25
Q

Are aminoglycosides concentration or time dependent? Cidal/static?

A

Concentration dependent bactericidal activity

26
Q

What does the absorption look like for aminoglycosides? Preferred ROA?

A

Poorly absorbed from GI tract, must use parenteral administration

IM injection

Intermittent IV infusion preferred (G,t,a,p)

27
Q

What are oral aminoglycosides

A

Oral neomycin and oral paramamycin

28
Q

When not to use IM injection for aminoglycosides

A

Hypotensive pts

29
Q

desscribe distribution of aminoglycosides (CSF, lungs, adipose) IBW or ADW for dosing?

A

Distribute poorly in CSF, lungs and adipose tissue

Use IBW (or ADW in obese patients) for dosing

30
Q

What are factors we must take into account when calculating dose for aminoglycoside

A

Volume status must be taken into account to calculate appropriate dose

31
Q

How are aminoglycosides eliminated? What does elimination half life depend on?

A

85-95% eliminated in kidneys

Elimination half life depends on renal function

32
Q

What is necessary monitoring required in ALL patients receiving aminoglcosides

A

Serum concentration monitoring is necessary in ALL pts

33
Q

Why do we monitor serum concentration for aminoglycoside

A

IT IS IMPERATIVE to achieve therapeutic concentrations quickly to decrease mortality

34
Q

When dosing Aminoglycosides, What is standard dosing based on? What does gram positive dosing come out as? What does gram negative dosing come out as?

A

Lading dose and maintenance dose based on Vd, IBW or ADW and desired peak

Gram positive synergy- 1mg/kg gent
gram negative-
LD- 2-2.5 g/kg/dose gent, tobra
MD- 1.5-2 mg/kg/dose gent, tobra

35
Q

What are the target peaks/troughs of gent and tobra for mod infection (UTI), mod-severe (SSTI, bacteremia), Severe (pneumonia, burn, life threat) Peak/trough for gram positive synergy (EXAM)

A

mod infection (UTI)- Peak= 4-6 mcg/ml, trough= 0.5-1.5 mcg/ml

Mod-severe (SSTI, bacteremia)- peak= 6-8, trough 1-1.5

Severe (pneumonia, burn, life threat)- Peak=8-10, trough=<2

Gram positive synergy- peak= 3-5 mcg/ml, Trough= 1 mcg/ml

36
Q

How to dose aminoglycosides once daily? What type of patients can we use this in?

A

Gent/tobra= 7 mg/kg. Use IBW or ADW

Only in gram negative bacteria and patients with normal Crcl (>40-50)

37
Q

target serum concentrations for QD dosing? (peak/trough) EXAM

A

Gent, tobra- Peak= 13-20, Trough <0.5
Amikacin- peak= 40-50, trough <8

38
Q

clinical uses of aminoglycosides? Which aminoglycosides are used for gram negative aerobes? Which are used with gram positive aerobes

A

Used in combination with cell modifying agents to treat gram negative aerobes and gram positive aerobes

Gent, tobra, amikacin used in gram negative aerobes. including pseuomonas aerioginosa in combination with B lactams

Gentamicin and streptomicin used for synergy with cell wall wall active agent for gram positive aerobes

Streptomicin used for TB

39
Q

What is plazomycin used for?

A

Complicated UTI due to MDR gram negative aerobes

40
Q

What are gram positive aerobes that we use gentamicin/streptomycin for?

A

Endocarditis due to enterococci
Viridians strep
Staph aureua (including NRSA)

41
Q

Adverse effects of aminoglycosides

A

Nephrotoxicity
Ototoxicity

42
Q

Risk factors for aminoglycosides nephrotoxiciy? ototoxicity?

A

Prolonged high troughs, long duration of therapy (>2 wks), underlying renal dysfunction, elderly, hypovolemia

Same risk factors

43
Q

Which of the following antibiotics does NOT have activity against pseudomonas aeruginosa. Cefepime, Ciprofloxacin, tobramycin, piperacillin, Ceftriaxone

A

Ceftriaxone

44
Q

Which antibiotic does NOT cause nephrotoxicity Gentamicin, Televancin, Vancomycin, Azithromycin, Nafcillin